查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1508419

雙相情感障礙治療市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2024-2034 年

Bipolar Disorder Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 143 Pages | 商品交期: 2-10個工作天內

價格

雙相情感障礙治療市場 - 報告範圍

TMR 關於全球雙相情感障礙治療市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2024 年至 2034 年預測期內市場指標的寶貴見解。 2018-2034年期間的市場，考慮2024年為基準年，2034年為預測年。該報告也提供了2024年至2034年全球雙極性情感疾患治療市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解雙相情感障礙治療市場。

市場概況
2023年市場價值 51 億美元
2034 年市場價值 92 億美元
複合年成長率 5.4%

該報告深入探討了全球雙極性情感障礙治療市場的競爭格局。全球雙相情感障礙治療市場的主要參與者已被確定，並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球雙相情感障礙治療市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020-2034年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 主要產品/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依治療類型

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依治療類型，2020-2034
    • 藥物治療
    • 心理治療
    • 電痙攣療法 (ECT)
    • 經顱磁刺激 (TMS)
    • 其他（住院等）
  • 市場吸引力：按治療類型分類

第 7 章：全球市場分析與預測：按藥物類別

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依藥品類別，2020-2034
    • 情緒穩定劑
    • 抗精神病藥
    • 抗憂鬱藥
    • 抗焦慮藥
    • 其他（抗驚厥藥等）
  • 市場吸引力：按藥品類別

第 8 章：全球市場分析與預測：依雙極性情感疾患類型

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：以雙極性情感疾患類型，2020-2034
    • I型雙極性情感障礙
    • II型雙極性情感障礙
    • 循環性障礙
    • 其他（特定和未特定的雙向情緒障礙及相關疾病等）
  • 市場吸引力：按雙極性情感障礙類型

第 9 章：全球市場分析與預測：按最終用戶

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2020-2034
    • 醫院
    • 專科診所
    • 心理健康中心
    • 門診手術中心
  • 市場吸引力：按最終用戶分類

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2020-2034
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力：按地區

第 11 章：北美市場分析與預測

第 12 章：歐洲市場分析與預測

第 13 章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2023）
  • 公司簡介
    • Otsuka Pharmaceutical Co., Ltd.
    • AstraZeneca plc
    • GSK plc
    • Pfizer Inc.
    • Eli Lilly and Company
    • Johnson & Johnson
    • AbbVie Inc.
    • Novartis AG
    • Allergan plc
    • Lundbeck A/S
Product Code: TMRGL20855

Bipolar Disorder Treatment Market - Scope of Report

TMR's report on the global bipolar disorder treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global bipolar disorder treatment market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global bipolar disorder treatment market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the bipolar disorder treatment market.

Market Snapshot
Market Value in 2023US$ 5.1 Bn
Market Value in 2034US$ 9.2 Bn
CAGR5.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global bipolar disorder treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global bipolar disorder treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global bipolar disorder treatment market.

The report delves into the competitive landscape of the global bipolar disorder treatment market. Key players operating in the global bipolar disorder treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global bipolar disorder treatment market profiled in this report.

Key Questions Answered in Global bipolar disorder treatment Market Report:

  • What is the sales/revenue generated by bipolar disorder treatment across all regions during the forecast period?
  • What are the opportunities in the global bipolar disorder treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Bipolar Disorder Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global bipolar disorder treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global bipolar disorder treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global bipolar disorder treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bipolar Disorder Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Bipolar Disorder Treatment Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Type of Treatment

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type of Treatment, 2020-2034
    • 6.3.1. Pharmacotherapy
    • 6.3.2. Psychotherapy
    • 6.3.3. Electroconvulsive Therapy (ECT)
    • 6.3.4. Transcranial Magnetic Stimulation (TMS)
    • 6.3.5. Others (Hospitalization, etc.)
  • 6.4. Market Attractiveness, by Type of Treatment

7. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Drug Class

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Drug Class, 2020-2034
    • 7.3.1. Mood Stabilizers
    • 7.3.2. Antipsychotics
    • 7.3.3. Anti-depressants
    • 7.3.4. Antianxiety Drugs
    • 7.3.5. Others (Anticonvulsants, etc.)
  • 7.4. Market Attractiveness, by Drug Class

8. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Type of Bipolar Disorder

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
    • 8.3.1. Bipolar I Disorder
    • 8.3.2. Bipolar II Disorder
    • 8.3.3. Cyclothymic Disorder
    • 8.3.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  • 8.4. Market Attractiveness, by Type of Bipolar Disorder

9. Global Bipolar Disorder Treatment Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020-2034
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Clinics
    • 9.3.3. Mental Health Centers
    • 9.3.4. Ambulatory Surgical Centers
  • 9.4. Market Attractiveness, by End-user

10. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2034
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Bipolar Disorder Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type of Treatment, 2020-2034
    • 11.2.1. Pharmacotherapy
    • 11.2.2. Psychotherapy
    • 11.2.3. Electroconvulsive Therapy (ECT)
    • 11.2.4. Transcranial Magnetic Stimulation (TMS)
    • 11.2.5. Others (Hospitalization, etc.)
  • 11.3. Market Attractiveness, by Type of Treatment
  • 11.4. Market Value Forecast, by Drug Class, 2020-2034
    • 11.4.1. Mood Stabilizers
    • 11.4.2. Antipsychotics
    • 11.4.3. Anti-depressants
    • 11.4.4. Antianxiety Drugs
    • 11.4.5. Others (Anticonvulsants, etc.)
  • 11.5. Market Attractiveness, by Drug Class
  • 11.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
    • 11.6.1. Bipolar I Disorder
    • 11.6.2. Bipolar II Disorder
    • 11.6.3. Cyclothymic Disorder
    • 11.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  • 11.7. Market Attractiveness, by Type of Bipolar Disorder
  • 11.8. Market Value Forecast, by End-user, 2020-2034
    • 11.8.1. Hospitals
    • 11.8.2. Specialty Clinics
    • 11.8.3. Mental Health Centers
    • 11.8.4. Ambulatory Surgical Centers
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Type of Treatment
    • 11.11.2. By Drug Class
    • 11.11.3. By Type of Bipolar Disorder
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe Bipolar Disorder Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type of Treatment, 2020-2034
    • 12.2.1. Pharmacotherapy
    • 12.2.2. Psychotherapy
    • 12.2.3. Electroconvulsive Therapy (ECT)
    • 12.2.4. Transcranial Magnetic Stimulation (TMS)
    • 12.2.5. Others (Hospitalization, etc.)
  • 12.3. Market Attractiveness, by Type of Treatment
  • 12.4. Market Value Forecast, by Drug Class, 2020-2034
    • 12.4.1. Mood Stabilizers
    • 12.4.2. Antipsychotics
    • 12.4.3. Anti-depressants
    • 12.4.4. Antianxiety Drugs
    • 12.4.5. Others (Anticonvulsants, etc.)
  • 12.5. Market Attractiveness, by Drug Class
  • 12.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
    • 12.6.1. Bipolar I Disorder
    • 12.6.2. Bipolar II Disorder
    • 12.6.3. Cyclothymic Disorder
    • 12.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  • 12.7. Market Attractiveness, by Type of Bipolar Disorder
  • 12.8. Market Value Forecast, by End-user, 2020-2034
    • 12.8.1. Hospitals
    • 12.8.2. Specialty Clinics
    • 12.8.3. Mental Health Centers
    • 12.8.4. Ambulatory Surgical Centers
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Type of Treatment
    • 12.11.2. By Drug Class
    • 12.11.3. By Type of Bipolar Disorder
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Bipolar Disorder Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type of Treatment, 2020-2034
    • 13.2.1. Pharmacotherapy
    • 13.2.2. Psychotherapy
    • 13.2.3. Electroconvulsive Therapy (ECT)
    • 13.2.4. Transcranial Magnetic Stimulation (TMS)
    • 13.2.5. Others (Hospitalization, etc.)
  • 13.3. Market Attractiveness, by Type of Treatment
  • 13.4. Market Value Forecast, by Drug Class, 2020-2034
    • 13.4.1. Mood Stabilizers
    • 13.4.2. Antipsychotics
    • 13.4.3. Anti-depressants
    • 13.4.4. Antianxiety Drugs
    • 13.4.5. Others (Anticonvulsants, etc.)
  • 13.5. Market Attractiveness, by Drug Class
  • 13.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
    • 13.6.1. Bipolar I Disorder
    • 13.6.2. Bipolar II Disorder
    • 13.6.3. Cyclothymic Disorder
    • 13.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  • 13.7. Market Attractiveness, by Type of Bipolar Disorder
  • 13.8. Market Value Forecast, by End-user, 2020-2034
    • 13.8.1. Hospitals
    • 13.8.2. Specialty Clinics
    • 13.8.3. Mental Health Centers
    • 13.8.4. Ambulatory Surgical Centers
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Type of Treatment
    • 13.11.2. By Drug Class
    • 13.11.3. By Type of Bipolar Disorder
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America Bipolar Disorder Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type of Treatment, 2020-2034
    • 14.2.1. Pharmacotherapy
    • 14.2.2. Psychotherapy
    • 14.2.3. Electroconvulsive Therapy (ECT)
    • 14.2.4. Transcranial Magnetic Stimulation (TMS)
    • 14.2.5. Others (Hospitalization, etc.)
  • 14.3. Market Attractiveness, by Type of Treatment
  • 14.4. Market Value Forecast, by Drug Class, 2020-2034
    • 14.4.1. Mood Stabilizers
    • 14.4.2. Antipsychotics
    • 14.4.3. Anti-depressants
    • 14.4.4. Antianxiety Drugs
    • 14.4.5. Others (Anticonvulsants, etc.)
  • 14.5. Market Attractiveness, by Drug Class
  • 14.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
    • 14.6.1. Bipolar I Disorder
    • 14.6.2. Bipolar II Disorder
    • 14.6.3. Cyclothymic Disorder
    • 14.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  • 14.7. Market Attractiveness, by Type of Bipolar Disorder
  • 14.8. Market Value Forecast, by End-user, 2020-2034
    • 14.8.1. Hospitals
    • 14.8.2. Specialty Clinics
    • 14.8.3. Mental Health Centers
    • 14.8.4. Ambulatory Surgical Centers
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Type of Treatment
    • 14.11.2. By Drug Class
    • 14.11.3. By Type of Bipolar Disorder
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Bipolar Disorder Treatment Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Type of Treatment, 2020-2034
    • 15.2.1. Pharmacotherapy
    • 15.2.2. Psychotherapy
    • 15.2.3. Electroconvulsive Therapy (ECT)
    • 15.2.4. Transcranial Magnetic Stimulation (TMS)
    • 15.2.5. Others (Hospitalization, etc.)
  • 15.3. Market Attractiveness, by Type of Treatment
  • 15.4. Market Value Forecast, by Drug Class, 2020-2034
    • 15.4.1. Mood Stabilizers
    • 15.4.2. Antipsychotics
    • 15.4.3. Anti-depressants
    • 15.4.4. Antianxiety Drugs
    • 15.4.5. Others (Anticonvulsants, etc.)
  • 15.5. Market Attractiveness, by Drug Class
  • 15.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
    • 15.6.1. Bipolar I Disorder
    • 15.6.2. Bipolar II Disorder
    • 15.6.3. Cyclothymic Disorder
    • 15.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  • 15.7. Market Attractiveness, by Type of Bipolar Disorder
  • 15.8. Market Value Forecast, by End-user, 2020-2034
    • 15.8.1. Hospitals
    • 15.8.2. Specialty Clinics
    • 15.8.3. Mental Health Centers
    • 15.8.4. Ambulatory Surgical Centers
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Type of Treatment
    • 15.11.2. By Drug Class
    • 15.11.3. By Type of Bipolar Disorder
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2023)
  • 16.3. Company Profiles
    • 16.3.1. Otsuka Pharmaceutical Co., Ltd.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. AstraZeneca plc
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. GSK plc
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Pfizer Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Eli Lilly and Company
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Johnson & Johnson
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. AbbVie Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Novartis AG
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Allergan plc
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Lundbeck A/S
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Treatment, 2020-2034
  • Table 02: Global Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 03: Global Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 04: Global Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Bipolar Disorder, 2020-2034
  • Table 05: Global Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 06: North America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 07: North America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Treatment, 2020-2034
  • Table 08: North America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 09: North America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Bipolar Disorder, 2020-2034
  • Table 10: North America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 11: Europe Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Treatment, 2020-2034
  • Table 13: Europe Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 14: Europe Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Bipolar Disorder, 2020-2034
  • Table 15: Europe Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 16: Asia Pacific Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Treatment, 2020-2034
  • Table 18: Asia Pacific Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 19: Asia Pacific Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Bipolar Disorder, 2020-2034
  • Table 20: Asia Pacific Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 21: Latin America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Treatment, 2020-2034
  • Table 23: Latin America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 24: Latin America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Bipolar Disorder, 2020-2034
  • Table 25: Latin America Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 26: Middle East & Africa Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Treatment, 2020-2034
  • Table 28: Middle East & Africa Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 29: Middle East & Africa Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by Type of Bipolar Disorder, 2020-2034
  • Table 30: Middle East & Africa Bipolar Disorder Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Bipolar Disorder Treatment Market Size (US$ Bn), by Region, 2023 and 2034
  • Figure 02: Global Bipolar Disorder Treatment Market Revenue (US$ Bn), by Type of Treatment, 2023
  • Figure 03: Global Bipolar Disorder Treatment Market Value Share, by Type of Treatment, 2023
  • Figure 04: Global Bipolar Disorder Treatment Market Revenue (US$ Bn), by Drug Class, 2023
  • Figure 05: Global Bipolar Disorder Treatment Market Value Share, by Drug Class, 2023
  • Figure 06: Global Bipolar Disorder Treatment Market Revenue (US$ Bn), by Type of Bipolar Disorder, 2023
  • Figure 07: Global Bipolar Disorder Treatment Market Value Share, by Type of Bipolar Disorder, 2023
  • Figure 08: Global Bipolar Disorder Treatment Market Revenue (US$ Bn), by End-user, 2023
  • Figure 09: Global Bipolar Disorder Treatment Market Value Share, by End-user, 2023
  • Figure 10: Global Bipolar Disorder Treatment Market Value Share, by Region, 2023
  • Figure 11: Global Bipolar Disorder Treatment Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 12: Global Bipolar Disorder Treatment Market Value Share Analysis, by Type of Treatment, 2023 and 2034
  • Figure 13: Global Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Treatment, 2024-2034
  • Figure 14: Global Bipolar Disorder Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 15: Global Bipolar Disorder Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 16: Global Bipolar Disorder Treatment Market Value Share Analysis, by Type of Bipolar Disorder, 2023 and 2034
  • Figure 17: Global Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Bipolar Disorder, 2024-2034
  • Figure 18: Global Bipolar Disorder Treatment Market Revenue (US$ Bn), by End-user, 2023
  • Figure 19: Global Bipolar Disorder Treatment Market Value Share, by End-user, 2023
  • Figure 20: Global Bipolar Disorder Treatment Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 21: Global Bipolar Disorder Treatment Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 22: North America Bipolar Disorder Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 23: North America Bipolar Disorder Treatment Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 24: North America Bipolar Disorder Treatment Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 25: North America Bipolar Disorder Treatment Market Value Share Analysis, by Type of Treatment, 2023 and 2034
  • Figure 26: North America Bipolar Disorder Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 27: North America Bipolar Disorder Treatment Market Value Share Analysis, by Type of Bipolar Disorder, 2023 and 2034
  • Figure 28: North America Bipolar Disorder Treatment Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 29: North America Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Treatment, 2024-2034
  • Figure 30: North America Bipolar Disorder Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 31: North America Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Bipolar Disorder, 2024-2034
  • Figure 32: North America Bipolar Disorder Treatment Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 33: Europe Bipolar Disorder Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 34: Europe Bipolar Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 35: Europe Bipolar Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 36: Europe Bipolar Disorder Treatment Market Value Share Analysis, by Type of Treatment, 2023 and 2034
  • Figure 37: Europe Bipolar Disorder Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 38: Europe Bipolar Disorder Treatment Market Value Share Analysis, by Type of Bipolar Disorder, 2023 and 2034
  • Figure 39: Europe Bipolar Disorder Treatment Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 40: Europe Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Treatment, 2024-2034
  • Figure 41: Europe Bipolar Disorder Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 42: Europe Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Bipolar Disorder, 2024-2034
  • Figure 43: Europe Bipolar Disorder Treatment Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 44: Asia Pacific Bipolar Disorder Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 45: Asia Pacific Bipolar Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 46: Asia Pacific Bipolar Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 47: Asia Pacific Bipolar Disorder Treatment Market Value Share Analysis, by Type of Treatment, 2023 and 2034
  • Figure 48: Asia Pacific Bipolar Disorder Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 49: Asia Pacific Bipolar Disorder Treatment Market Value Share Analysis, by Type of Bipolar Disorder, 2023 and 2034
  • Figure 50: Asia Pacific Bipolar Disorder Treatment Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 51: Asia Pacific Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Treatment, 2024-2034
  • Figure 52: Asia Pacific Bipolar Disorder Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 53: Asia Pacific Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Bipolar Disorder, 2024-2034
  • Figure 54: Asia Pacific Bipolar Disorder Treatment Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 55: Latin America Bipolar Disorder Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 56: Latin America Bipolar Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 57: Latin America Bipolar Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 58: Latin America Bipolar Disorder Treatment Market Value Share Analysis, by Type of Treatment, 2023 and 2034
  • Figure 59: Latin America Bipolar Disorder Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 60: Latin America Bipolar Disorder Treatment Market Value Share Analysis, by Type of Bipolar Disorder, 2023 and 2034
  • Figure 61: Latin America Bipolar Disorder Treatment Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 62: Latin America Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Treatment, 2024-2034
  • Figure 63: Latin America Bipolar Disorder Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 64: Latin America Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Bipolar Disorder, 2024-2034
  • Figure 65: Latin America Bipolar Disorder Treatment Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Middle East & Africa Bipolar Disorder Treatment Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 67: Middle East & Africa Bipolar Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 68: Middle East & Africa Bipolar Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 69: Middle East & Africa Bipolar Disorder Treatment Market Value Share Analysis, by Type of Treatment, 2023 and 2034
  • Figure 70: Middle East & Africa Bipolar Disorder Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 71: Middle East & Africa Bipolar Disorder Treatment Market Value Share Analysis, by Type of Bipolar Disorder, 2023 and 2034
  • Figure 72: Middle East & Africa Bipolar Disorder Treatment Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 73: Middle East & Africa Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Treatment, 2024-2034
  • Figure 74: Middle East & Africa Bipolar Disorder Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 75: Middle East & Africa Bipolar Disorder Treatment Market Attractiveness Analysis, by Type of Bipolar Disorder, 2024-2034
  • Figure 76: Middle East & Africa Bipolar Disorder Treatment Market Attractiveness Analysis, by End-user, 2024-2034